Valuation
- Market cap
- 442,000
- Revenue TTM
- $64,830,000
- Net income TTM
- $-47,000,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -72.50%
- Debt to equity
- 1.60
Trading
- Volume
- 1,400
- Avg volume
- 238,248
- Day's range
- $0.27 – $0.38
- Shares out
- 1,424,000
- Stochastic %K
- 37%
- Beta
- -0.06
- Analysts
- —
- Price target
- $10.60
Company profile
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used...
Show more
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 877 848 8430
- Website
- https://www.venus.ai
- Address
- 235 Yorkland Boulevard, Suite 900, Toronto, Canada
Latest news
No headlines yet.